Skip to Content

Curaleaf Holdings Inc CURA

Morningstar Rating
CAD 5.30 −0.02 (0.38%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Curaleaf Positioned for Long-Term Growth From US and International Market Tailwinds

Curaleaf cultivates and sells cannabis in the US with a presence in 17 states. Vertically integrated, Curaleaf produces through 18 cultivation sites and sells directly through 145 dispensaries and wholesale to other dispensaries. Compared with other multistate operators, Curaleaf has generally employed a more aggressive growth strategy, which hasn't always paid off, leading to exits and sales.

Price vs Fair Value

CURA is trading at a 263% premium.
Price
CAD 5.30
Fair Value
CAD 35.50
Uncertainty
Very High
1-Star Price
CAD 28.97
5-Star Price
CAD 3.35
Economic Moat
Dwlg
Capital Allocation
Nxcvcmkdm

Bulls Say, Bears Say

Bulls

Unique among US multistate operators, Curaleaf's acquisitions into Europe and Canada allow it to serve the growing European market as legalization expands.

Bears

Sales growth for legal sellers like Curaleaf are challenged by the lack of taxes in the illicit market.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CURA is a good fit for your portfolio.

News

Trading Information

Previous Close Price
CAD 5.32
Day Range
CAD 5.215.37
52-Week Range
CAD 4.588.73
Bid/Ask
CAD 5.29 / CAD 5.29
Market Cap
CAD 3.93 Bil
Volume/Avg
93,249 / 401,290

Key Statistics

Price/Earnings (Normalized)
Price/Sales
2.11
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
5,650
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
VxrsgxzwdCwn$80.1 Bil
Merck KGaA ADR
MKKGY
PnfqkgvnKmzvdvw$71.6 Bil
Haleon PLC ADR
HLN
GnsbvwmtDqhwd$37.5 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
JjzpxvzwKypsw$18.9 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
HxybnwzdMwd$12.9 Bil
Viatris Inc
VTRS
MshfljffKty$12.4 Bil
Catalent Inc
CTLT
KgsdlxnnvDxcbfm$10.2 Bil
Perrigo Co PLC
PRGO
DrsxxcrpGmz$3.6 Bil
Prestige Consumer Healthcare Inc
PBH
BhtjhspvPxgyd$3.4 Bil
Curaleaf Holdings Inc
CURLF
LgyphprKzgr$2.9 Bil

Sponsor Center